|
|
Volumn 42, Issue 8, 2013, Pages 1311-1315
|
|
Modified FOLFIRINOX regimen with improved safety and maintained efficacy in pancreatic adenocarcinoma
a
a
a
a
b
a,b
c
c
d
a
|
|
Author keywords
bolus 5 FU; borderline resectable; FOLFIRINOX; locally advanced; pancreas cancer; toxicity
|
|
Indexed keywords
FLUOROURACIL;
FOLINIC ACID;
HEMOPOIETIC GROWTH FACTOR;
IRINOTECAN;
OXALIPLATIN;
ADULT;
AGED;
ALLERGIC REACTION;
ARTICLE;
BORDERLINE STATE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CHEMORADIOTHERAPY;
DIARRHEA;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG SAFETY;
FATIGUE;
FEMALE;
HUMAN;
INFECTION;
MAJOR CLINICAL STUDY;
MALE;
MUCOSA INFLAMMATION;
MULTIMODALITY CANCER THERAPY;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
OVERALL SURVIVAL;
PANCREAS ADENOCARCINOMA;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RETROSPECTIVE STUDY;
THROMBOCYTOPENIA;
TREATMENT DURATION;
VOMITING;
ADENOCARCINOMA;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CA-19-9 ANTIGEN;
CAMPTOTHECIN;
DIARRHEA;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FATIGUE;
FEMALE;
FLUOROURACIL;
FOLLOW-UP STUDIES;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HUMANS;
LEUCOVORIN;
MALE;
MIDDLE AGED;
NEUTROPENIA;
ORGANOPLATINUM COMPOUNDS;
PANCREATIC NEOPLASMS;
RECOMBINANT PROTEINS;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
|
|
EID: 84887272144
PISSN: 08853177
EISSN: 15364828
Source Type: Journal
DOI: 10.1097/MPA.0b013e31829e2006 Document Type: Article |
|
Times cited : (170)
|
|
References (9)
|
